Focus: Infection Control

FDA says healthcare facilities should use safer scopes

Agency suggests companies make disposable versions


The Food and Drug Administration (FDA) said companies that make duodenoscopes should begin making disposable versions, according to an article on The New York Times website.

The agency also said that hospitals should start to transition to models with disposable components to reduce the risk of infection.

FDA tests revealed that one in 20 harbored disease-causing microbes like E. coli even after being properly cleaned.

Medical experts have urged the FDA to force manufacturers to make the scopes safer and easier to decontaminate — or to take them off the market.

Read the article.



September 6, 2019


Topic Area: Infection Control


Recent Posts

Building Envelopes Emerge As Key Facility Components

From enclosure commissioning and air-moisture control to decarbonization and thermal comfort, exterior systems affect energy efficiency and resilience.


Catholic Medical Center Breaks Ground on New Central Energy Plant

The new central energy plant is expected to be completed in early 2027.


Cottage Hospital Ensnared in Data Breach

On December 8, 2025, Cottage Hospital learned that an unauthorized party gained access to its computer network and took some of its files.


Biofilm 'Life Raft' Changes C. Auris Risk

Microscopic survival structure protects fungal pathogen from disinfectants and help it survive for long periods.


How Healthcare Restrooms Are Rethinking Water Efficiency

Manufacturers discuss strategies, technologies and design approaches that help healthcare facilities meet their sustainability goals.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.